DOCSLIB.ORG

Supplementary Table 1 Genes Tested in Qrt-PCR in Nfpas

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplementary Table 1 Genes Tested in Qrt-PCR in Nfpas Supplementary Table 1 Genes tested in qRT-PCR in NFPAs Gene Bank accession Gene Description number ABI assay ID a disintegrin-like and metalloprotease with thrombospondin type 1 motif 7 ADAMTS7 NM_014272.3 Hs00276223_m1 Rho guanine nucleotide exchange factor (GEF) 3 ARHGEF3 NM_019555.1 Hs00219609_m1 BCL2-associated X protein BAX NM_004324 House design Bcl-2 binding component 3 BBC3 NM_014417.2 Hs00248075_m1 B-cell CLL/lymphoma 2 BCL2 NM_000633 House design Bone morphogenetic protein 7 BMP7 NM_001719.1 Hs00233476_m1 CCAAT/enhancer binding protein (C/EBP), alpha CEBPA NM_004364.2 Hs00269972_s1 coxsackie virus and adenovirus receptor CXADR NM_001338.3 Hs00154661_m1 Homo sapiens Dicer1, Dcr-1 homolog (Drosophila) (DICER1) DICER1 NM_177438.1 Hs00229023_m1 Homo sapiens dystonin DST NM_015548.2 Hs00156137_m1 fms-related tyrosine kinase 3 FLT3 NM_004119.1 Hs00174690_m1 glutamate receptor, ionotropic, N-methyl D-aspartate 1 GRIN1 NM_000832.4 Hs00609557_m1 high-mobility group box 1 HMGB1 NM_002128.3 Hs01923466_g1 heterogeneous nuclear ribonucleoprotein U HNRPU NM_004501.3 Hs00244919_m1 insulin-like growth factor binding protein 5 IGFBP5 NM_000599.2 Hs00181213_m1 latent transforming growth factor beta binding protein 4 LTBP4 NM_001042544.1 Hs00186025_m1 microtubule-associated protein 1 light chain 3 beta MAP1LC3B NM_022818.3 Hs00797944_s1 matrix metallopeptidase 17 MMP17 NM_016155.4 Hs01108847_m1 myosin VA MYO5A NM_000259.1 Hs00165309_m1 Homo sapiens nuclear factor (erythroid-derived 2)-like 1 NFE2L1 NM_003204.1 Hs00231457_m1 oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) OGDH NM_002541.2 Hs00159768_m1 oxysterol binding protein OSBP NM_002556.2 Hs00387304_m1 phosphoinositide-3-kinase, catalytic, beta polypeptide PIK3CB NM_006219.1 Hs00178872_m1 Homo sapiens peroxiredoxin 2 PRDX2 NM_181738.1 Hs00428488_g1 RAB1, member RAS oncogene family RAB1A NM_004161.3 Hs00800204_s1 ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein) RAC1 NM_006908.3 House design v-ski avian sarcoma viral oncogene homolog SKI NM_003036.1 Hs00161707_m1 synaptosomal-associated protein, 25kD SNAP25 NM_003081.2 Hs00268296_m1 SNAP-associated protein SNAPAP NM_012437.3 Hs00276176_m1 somatostatin receptor 1 SSTR1 NM_001049.2 Hs00265617_s1 thromboxane A synthase 1 TBXAS1 NM_030984.1 Hs00233423_m1 TRK-fused gene TFG NM_006070.4 Hs00607175_m1 ubiquitin-conjugating enzyme E2L 3 UBE2L3 NM_003347.2 Hs00748530_s1 uncoupling protein 3 UCP3 NM_022803.1 Hs00243297_m1 Housekeeping gene Ribosomal Phosphoprotein PO RPLO NM_001002 House design Supplementary Table 2- Bioinformatic analysis results using Class Prediction analysis (BrB software) in 22 invasive and 18 non invasive NFPAs Geom mean Geom mean Parametric of ratios in of ratios in t-value Description Gene symbol p-value invasive Non invasive tumors tumors 1 Homo sapiens dystonin (DST), transcript variant 1eA, -7.18 p < 0.000001 0.512 0.861 mRNA [NM_015548] DST 2 -6.82 p < 0.000001 0.576 0.975 hypothetical protein LOC284889 LOC284889 3 Homo sapiens chromosome 3 open reading frame 10 -6.57 p < 0.000001 0.511 0.785 (C3orf10), mRNA [NM_018462] C3orf10 4 -6.43 p < 0.000001 0.323 0.568 Unknown THC2174081 5 -6.34 p < 0.000001 0.423 0.679 ubiquitin-conjugating enzyme E2L 3 UBE2L3 6 Homo sapiens cDNA FLJ42306 fis, clone TRACH2001646. -6.15 p < 0.000001 0.543 0.879 [AK124299] PPM1A 7 -5.83 p < 0.000001 0.534 0.916 coxsackie virus and adenovirus receptor CXADR 8 full-length cDNA clone CS0DI054YK17 of Placenta Cot 25- -5.8 1,00E-06 0.465 0.697 normalized of Homo sapiens (human). [CR618720] CR618720 9 Homo sapiens cDNA FLJ34585 fis, clone KIDNE2008758. -5.77 1,00E-06 0.641 1.026 [AK091904] AK091904 10 -5.77 1,00E-06 0.622 0.887 C9orf10 protein C9orf10 11 -5.76 1,00E-06 0.401 0.654 Unknown A_24_P375076 12 -5.7 1,00E-06 0.552 0.893 Unknown A_24_P264597 13 -5.69 2,00E-06 0.563 0.83 TRK-fused gene TFG 14 -5.64 2,00E-06 0.475 0.768 RAB1, member RAS oncogene family RAB1A 15 -5.62 2,00E-06 0.47 0.781 LIN-7 protein 3 LIN7C 16 -5.57 2,00E-06 0.411 0.721 synaptosomal-associated protein, 25kD SNAP25 17 Homo sapiens sorting nexin 3 (SNX3), transcript variant 3, -5.54 2,00E-06 0.592 0.916 mRNA [NM_152828] SNX3 18 Homo sapiens Dicer1, Dcr-1 homolog (Drosophila) -5.49 3,00E-06 0.525 0.846 (DICER1), transcript variant 1, mRNA [NM_177438] DICER1 19 Homo sapiens hypothetical protein MGC29463 -5.43 3,00E-06 0.62 0.905 (MGC29463), mRNA [NM_152686] DNAJC18 20 -5.35 4,00E-06 0.539 0.929 KIAA0940 protein CPEB3 21 -5.31 5,00E-06 0.565 0.836 lysyl-tRNA synthetase KARS 22 -5.22 7,00E-06 0.635 0.92 selenoprotein T SELT 23 Homo sapiens Cohen syndrome 1 (COH1), transcript -4.96 1.5e-05 0.534 0.812 variant 2, mRNA [NM_184042] VPS13B 24 -4.93 1.6e-05 0.567 0.809 hypothetical protein LOC339210 LOC339210 25 -4.93 1.7e-05 0.594 0.932 KIAA0940 protein CPEB3 26 Homo sapiens retinoic acid induced 17 (RAI17), mRNA -4.93 1.7e-05 0.621 0.912 [NM_020338] RAI17 27 -4.92 1.7e-05 0.53 0.789 BCE-1 protein TLE4 Homo sapiens peroxiredoxin 2 (PRDX2), nuclear gene 28 encoding mitochondrial protein, transcript variant 3, mRNA -4.87 2,00E-05 0.475 0.743 [NM_181738] PRDX2 29 -4.84 2.2e-05 0.582 0.865 DnaJ (Hsp40) homolog, subfamily B, member 6 DNAJB6 30 -4.8 2.5e-05 0.574 0.871 p53 regulated PA26 nuclear protein SESN1 31 -4.77 2.7e-05 0.493 0.759 hypothetical protein FLJ11220 RSBN1 32 -4.76 2.8e-05 0.537 0.792 3-phosphoinositide dependent protein kinase-1 PDPK1 33 -4.71 3.3e-05 0.687 1.001 similar to bA508N22.1 (HSPC025) LOC340947 34 -4.7 3.4e-05 0.551 0.819 KIAA0416 protein LRRTM2 35 -4.69 3.4e-05 0.541 0.8 hypothetical protein PRO1855 PRO1855 36 -4.68 3.6e-05 0.58 0.835 HT014 C1orf128 37 -4.65 4,00E-05 0.596 0.819 Unknown A_24_P417996 38 -4.64 4.1e-05 0.583 0.899 neurexin 1 NRXN1 39 -4.62 4.3e-05 0.572 0.826 Unknown ENST00000331458 40 -4.61 4.5e-05 0.627 0.98 F-box only protein 9 FBXO9 41 -4.6 4.6e-05 0.662 0.987 hypothetical protein MGC5391 SFT2D3 42 -4.59 4.8e-05 0.691 1.074 zinc finger protein 347 ZNF347 43 ALU7_HUMAN (P39194) Alu subfamily SQ sequence -4.58 4.8e-05 0.642 0.943 contamination warning entry, partial (12%) [THC2206574] THC2206574 44 -4.56 5.2e-05 0.507 0.774 hypothetical protein MGC14961 NAV1 45 -4.54 5.5e-05 0.499 0.797 hypothetical gene supported by BX647608 LOC399959 46 -4.54 5.5e-05 0.436 0.677 Unknown A_24_P264004 47 DNA directed RNA polymerase II polypeptide J-related -4.53 5.7e-05 0.503 0.71 gene POLR2J2 48 -4.43 7.8e-05 0.436 0.725 clock (mouse) homolog CLOCK 49 -4.41 8.2e-05 0.383 0.758 KIAA0878 protein RHOBTB3 50 RL1X_HUMAN (Q02543) 60S ribosomal protein L18a, -4.4 8.4e-05 0.574 0.798 partial (98%) [THC2071427] THC2071427 51 -4.35 9.8e-05 0.565 0.788 Unknown A_24_P164815 52 -4.33 0.000103 0.944 1.305 signal recognition particle 9kD SRP9 53 -4.33 0.000105 0.311 0.585 serine/threonine kinase 9 CDKL5 54 -4.32 0.000109 0.655 0.908 membrane component, chromosome 11, surface marker 1 GPIAP1 55 -4.31 0.00011 0.57 0.823 MORF-related gene 15 MORF4L1 56 -4.31 0.000111 0.637 0.95 ribosomal protein S5 RPS5 57 Homo sapiens DKFZP564F0522 protein -4.3 0.000115 0.613 0.892 (DKFZP564F0522), mRNA [NM_015475] FAM98A 58 -4.26 0.000128 0.56 0.783 hypothetical protein MGC3121 MGC3121 59 protein kinase, cAMP-dependent, regulatory, type I, alpha -4.26 0.000129 0.636 0.928 (tissue specific extinguisher 1) PRKAR1A 60 -4.24 0.000136 0.539 0.869 formin 2 FMN2 61 -4.24 0.000137 0.539 0.77 phosphoinositide-3-kinase, catalytic, beta polypeptide PIK3CB 62 -4.22 0.000147 0.516 0.806 hypothetical protein DKFZP434I0714 DKFZP434I0714 63 -4.2 0.000153 0.539 0.818 Unknown A_24_P384422 64 Homo sapiens WNK lysine deficient protein kinase 3 -4.18 0.000166 0.418 0.719 (WNK3), transcript variant 1, mRNA [NM_020922] WNK3 65 ALU1_HUMAN (P39188) Alu subfamily J sequence -4.16 0.000175 0.555 0.843 contamination warning entry, partial (6%) [THC2054351] THC2054351 66 -4.15 0.00018 0.717 0.971 mammalian inositol hexakisphosphate kinase 2 IHPK2 67 -4.14 0.000185 0.683 0.94 fused toes (mouse) homolog FTS 68 Homo sapiens clone FLC0675 PRO2870 mRNA, complete -4.13 0.000191 0.502 0.715 cds. [AF130080] AF130080 69 -4.13 0.000191 0.554 0.785 DKFZP586G1722 protein C1orf43 70 BIM_HUMAN (O43521) Bcl-2-like protein 11 (Bcl2 -4.11 0.000202 0.633 0.947 interacting mediator of cell death), complete [THC2172353] THC2172359 71 -4.11 0.000202 0.622 0.877 similar to hypothetical protein MNCb-2386 MED8 72 -4.11 0.000203 0.636 0.869 ribosomal protein L18a RPL18A 73 Homo sapiens hypothetical protein LOC127262 -4.08 0.000223 0.566 0.815 (LOC127262), mRNA [NM_182752] FAM79A 74 -4.08 0.000225 0.452 0.714 Kaiso ZBTB33 75 -4.06 0.000237 0.662 0.929 hypothetical protein HSPC177 CHMP5 76 -4.04 0.000251 0.547 0.869 sodium channel, voltage-gated, type III, alpha polypeptide SCN3A 77 -4.03 0.000256 0.521 0.813 ribosomal protein S6 kinase, 90kD, polypeptide 5 RPS6KA5 78 -4.02 0.000268 0.685 0.98 p53 regulated PA26 nuclear protein SESN1 79 Homo sapiens mRNA; cDNA DKFZp547H074 (from clone -3.96 0.000317 0.572 0.933 DKFZp547H074).
Load more

Recommended publications
  • Wo 2010/075007 A2
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date 1 July 2010 (01.07.2010) WO 2010/075007 A2 (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C12Q 1/68 (2006.01) G06F 19/00 (2006.01) kind of national protection available): AE, AG, AL, AM, C12N 15/12 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, (21) International Application Number: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/US2009/067757 HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 11 December 2009 ( 11.12.2009) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, (25) Filing Language: English SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, (26) Publication Language: English TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 12/3 16,877 16 December 2008 (16.12.2008) US kind of regional protection available): ARIPO (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, (71) Applicant (for all designated States except US): DODDS, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, W., Jean [US/US]; 938 Stanford Street, Santa Monica, TM), European (AT, BE, BG, CH, CY, CZ, DE, DK, EE, CA 90403 (US).
    [Show full text]
  • The Spectraplakin Dystonin Antagonizes YAP Activity and Suppresses Tumourigenesis Praachi B
    www.nature.com/scientificreports OPEN The spectraplakin Dystonin antagonizes YAP activity and suppresses tumourigenesis Praachi B. Jain1,2,3, Patrícia S. Guerreiro1,2,3, Sara Canato1,2,3 & Florence Janody 1,2,3* Aberrant expression of the Spectraplakin Dystonin (DST) has been observed in various cancers, including those of the breast. However, little is known about its role in carcinogenesis. In this report, we demonstrate that Dystonin is a candidate tumour suppressor in breast cancer and provide an underlying molecular mechanism. We show that in MCF10A cells, Dystonin is necessary to restrain cell growth, anchorage-independent growth, self-renewal properties and resistance to doxorubicin. Strikingly, while Dystonin maintains focal adhesion integrity, promotes cell spreading and cell-substratum adhesion, it prevents Zyxin accumulation, stabilizes LATS and restricts YAP activation. Moreover, treating DST- depleted MCF10A cells with the YAP inhibitor Verteporfn prevents their growth. In vivo, the Drosophila Dystonin Short stop also restricts tissue growth by limiting Yorkie activity. As the two Dystonin isoforms BPAG1eA and BPAG1e are necessary to inhibit the acquisition of transformed features and are both downregulated in breast tumour samples and in MCF10A cells with conditional induction of the Src proto-oncogene, they could function as the predominant Dystonin tumour suppressor variants in breast epithelial cells. Thus, their loss could deem as promising prognostic biomarkers for breast cancer. Breast cancer progression depends on cell autonomous regulatory mechanisms, driven by mutations and epi- genetic changes, and on non-cell autonomous interactions with the surrounding tumour microenvironment1,2. During this multistep process, normal breast epithelial cells acquire various cellular properties arising from dereg- ulated cellular signalling3,4.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Drp1 Overexpression Induces Desmin Disassembling and Drives Kinesin-1 Activation Promoting Mitochondrial Trafficking in Skeletal Muscle
    Cell Death & Differentiation (2020) 27:2383–2401 https://doi.org/10.1038/s41418-020-0510-7 ARTICLE Drp1 overexpression induces desmin disassembling and drives kinesin-1 activation promoting mitochondrial trafficking in skeletal muscle 1 1 2 2 2 3 Matteo Giovarelli ● Silvia Zecchini ● Emanuele Martini ● Massimiliano Garrè ● Sara Barozzi ● Michela Ripolone ● 3 1 4 1 5 Laura Napoli ● Marco Coazzoli ● Chiara Vantaggiato ● Paulina Roux-Biejat ● Davide Cervia ● 1 1 2 1,4 6 Claudia Moscheni ● Cristiana Perrotta ● Dario Parazzoli ● Emilio Clementi ● Clara De Palma Received: 1 August 2019 / Revised: 13 December 2019 / Accepted: 23 January 2020 / Published online: 10 February 2020 © The Author(s) 2020. This article is published with open access Abstract Mitochondria change distribution across cells following a variety of pathophysiological stimuli. The mechanisms presiding over this redistribution are yet undefined. In a murine model overexpressing Drp1 specifically in skeletal muscle, we find marked mitochondria repositioning in muscle fibres and we demonstrate that Drp1 is involved in this process. Drp1 binds KLC1 and enhances microtubule-dependent transport of mitochondria. Drp1-KLC1 coupling triggers the displacement of KIF5B from 1234567890();,: 1234567890();,: kinesin-1 complex increasing its binding to microtubule tracks and mitochondrial transport. High levels of Drp1 exacerbate this mechanism leading to the repositioning of mitochondria closer to nuclei. The reduction of Drp1 levels decreases kinesin-1 activation and induces the partial recovery of mitochondrial distribution. Drp1 overexpression is also associated with higher cyclin-dependent kinase-1 (Cdk-1) activation that promotes the persistent phosphorylation of desmin at Ser-31 and its disassembling. Fission inhibition has a positive effect on desmin Ser-31 phosphorylation, regardless of Cdk-1 activation, suggesting that induction of both fission and Cdk-1 are required for desmin collapse.
    [Show full text]
  • This Is an Author Produced Version of a Paper Published in Immunology
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Publications from Karolinska Institutet This is an author produced version of a paper published in Immunology. This paper has been peer-reviewed but does not include the final publisher proof-corrections or journal pagination. Pubmed citation for the paper: Immunology. 2014 May 6. [Epub ahead of print] Ligation of human Fc receptor like-2 (FCRL2) by monoclonal antibodies downregulates B cell receptor mediated signaling. Shabani M, Bayat AA, Jeddi-Tehrani M, Rabbani H, Hojjat-Farsangi M, Ulivieri C, Amirghofran Z, Baldari CT, Shokri F. URL: http://dx.doi.org/10.1111/imm.12311 Access to the published version may require subscription. Published with permission from: Wiley Ligation of human Fc receptor like-2 (FCRL2) by monoclonal antibodies downregulates B cell receptor mediated signaling Mahdi Shabania,b, Ali Ahmad Bayata, Mahmood Jeddi-Tehrania, Hodjatallah Rabbania,c, Mohammad Hojjat-Farsangid, Cristina Ulivierie, Zahra Amirghofranb, Cosima Tatiana Baldarie and Fazel Shokria,f* a Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran b Department of Immunology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran c Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, SE-14186 Stockholm, Sweden d Immune and Gene Therapy Laboratory, Cancer Centre Karolinska, Department of Oncology-Pathology, Karolinska Institutet, Stockholm e Department of Life Sciences, University of Siena, Siena, Italy f Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran *Corresponding author: Fazel Shokri, Ph.D., Professor, Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran, P.O.
    [Show full text]
  • Anti-IDH3A Antibody (ARG42205)
    Product datasheet [email protected] ARG42205 Package: 100 μl anti-IDH3A antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes IDH3A Tested Reactivity Hu, Ms, Rat Tested Application ICC/IF, IHC-P, WB Host Rabbit Clonality Polyclonal Isotype IgG Target Name IDH3A Antigen Species Human Immunogen Recombinant fusion protein corresponding to aa. 28-366 of Human IDH3A (NP_005521.1). Conjugation Un-conjugated Alternate Names Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial; EC 1.1.1.41; NAD; Isocitric dehydrogenase subunit alpha; + Application Instructions Application table Application Dilution ICC/IF 1:50 - 1:200 IHC-P 1:50 - 1:200 WB 1:500 - 1:2000 Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Positive Control Raji Calculated Mw 40 kDa Observed Size ~ 40 kDa Properties Form Liquid Purification Affinity purified. Buffer PBS (pH 7.3), 0.02% Sodium azide and 50% Glycerol. Preservative 0.02% Sodium azide Stabilizer 50% Glycerol Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw www.arigobio.com 1/3 cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. Note For laboratory research only, not for drug, diagnostic or other use. Bioinformation Gene Symbol IDH3A Gene Full Name isocitrate dehydrogenase 3 (NAD+) alpha Background Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate.
    [Show full text]
  • A Misplaced Lncrna Causes Brachydactyly in Humans
    A misplaced lncRNA causes brachydactyly in humans Philipp G. Maass, … , Friedrich C. Luft, Sylvia Bähring J Clin Invest. 2012;122(11):3990-4002. https://doi.org/10.1172/JCI65508. Research Article Translocations are chromosomal rearrangements that are frequently associated with a variety of disease states and developmental disorders. We identified 2 families with brachydactyly type E (BDE) resulting from different translocations affecting chromosome 12p. Both translocations caused downregulation of the parathyroid hormone-like hormone (PTHLH) gene by disrupting the cis-regulatory landscape. Using chromosome conformation capturing, we identified a regulator on chromosome 12q that interacts in cis with PTHLH over a 24.4-megabase distance and in trans with the sex- determining region Y-box 9 (SOX9) gene on chromosome 17q. The element also harbored a long noncoding RNA (lncRNA). Silencing of the lncRNA, PTHLH, or SOX9 revealed a feedback mechanism involving an expression-dependent network in humans. In the BDE patients, the human lncRNA was upregulated by the disrupted chromosomal association. Moreover, the lncRNA occupancy at the PTHLH locus was reduced. Our results document what we believe to be a novel in cis– and in trans–acting DNA and lncRNA regulatory feedback element that is reciprocally regulated by coding genes. Furthermore, our findings provide a systematic and combinatorial view of how enhancers encoding lncRNAs may affect gene expression in normal development. Find the latest version: https://jci.me/65508/pdf Research article Related Commentary, page 3837 A misplaced lncRNA causes brachydactyly in humans Philipp G. Maass,1,2 Andreas Rump,3 Herbert Schulz,2 Sigmar Stricker,4 Lisanne Schulze,1,2 Konrad Platzer,3 Atakan Aydin,1,2 Sigrid Tinschert,3 Mary B.
    [Show full text]
  • Smooth Muscle-Specific MMP17 (MT4-MMP) Defines the Intestinal ECM Niche 2 3 Mara Martín-Alonso1*, Håvard T
    bioRxiv preprint doi: https://doi.org/10.1101/2020.06.18.147769; this version posted June 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Smooth muscle-specific MMP17 (MT4-MMP) defines the intestinal ECM niche 2 3 Mara Martín-Alonso1*, Håvard T. Lindholm1,# , Sharif Iqbal2,3,#, Pia Vornewald1#, Sigrid Hoel1, 4 Mirjam J. Damen4, A.F.Maarten Altelaar4, Pekka Katajisto2,3,5, Alicia G. Arroyo6,7, Menno J. 5 Oudhoff1* 6 7 1CEMIR – Centre of Molecular Inflammation Research, Department of Clinical and Molecular 8 Medicine, NTNU – Norwegian University of Science and Technology, 7491 Trondheim, 9 Norway 10 2Institute of Biotechnology, HiLIFE, University of Helsinki, Finland 11 3Molecular and Integrative Bioscience Research Programme, Faculty of Biological and 12 Environmental Sciences, University of Helsinki, Helsinki, Finland 13 4Biomolecular Mass Spectrometry and Proteomics, Utrecht University, Utrecht, The 14 Netherlands 15 5Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden 16 6Centro de Investigaciones Biológicas Margarita Salas (CIB-CSIC), Madrid, Spain 17 7Vascular Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares 18 (CNIC), Madrid, Spain.CNIC, Madrid, Spain 19 20 #These authors contributed equally to this work 21 *corresponding authors, e-mail: [email protected], [email protected] 22 bioRxiv preprint doi: https://doi.org/10.1101/2020.06.18.147769; this version posted June 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Noelia Díaz Blanco
    Effects of environmental factors on the gonadal transcriptome of European sea bass (Dicentrarchus labrax), juvenile growth and sex ratios Noelia Díaz Blanco Ph.D. thesis 2014 Submitted in partial fulfillment of the requirements for the Ph.D. degree from the Universitat Pompeu Fabra (UPF). This work has been carried out at the Group of Biology of Reproduction (GBR), at the Department of Renewable Marine Resources of the Institute of Marine Sciences (ICM-CSIC). Thesis supervisor: Dr. Francesc Piferrer Professor d’Investigació Institut de Ciències del Mar (ICM-CSIC) i ii A mis padres A Xavi iii iv Acknowledgements This thesis has been made possible by the support of many people who in one way or another, many times unknowingly, gave me the strength to overcome this "long and winding road". First of all, I would like to thank my supervisor, Dr. Francesc Piferrer, for his patience, guidance and wise advice throughout all this Ph.D. experience. But above all, for the trust he placed on me almost seven years ago when he offered me the opportunity to be part of his team. Thanks also for teaching me how to question always everything, for sharing with me your enthusiasm for science and for giving me the opportunity of learning from you by participating in many projects, collaborations and scientific meetings. I am also thankful to my colleagues (former and present Group of Biology of Reproduction members) for your support and encouragement throughout this journey. To the “exGBRs”, thanks for helping me with my first steps into this world. Working as an undergrad with you Dr.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • (P -Value<0.05, Fold Change≥1.4), 4 Vs. 0 Gy Irradiation
    Table S1: Significant differentially expressed genes (P -Value<0.05, Fold Change≥1.4), 4 vs. 0 Gy irradiation Genbank Fold Change P -Value Gene Symbol Description Accession Q9F8M7_CARHY (Q9F8M7) DTDP-glucose 4,6-dehydratase (Fragment), partial (9%) 6.70 0.017399678 THC2699065 [THC2719287] 5.53 0.003379195 BC013657 BC013657 Homo sapiens cDNA clone IMAGE:4152983, partial cds. [BC013657] 5.10 0.024641735 THC2750781 Ciliary dynein heavy chain 5 (Axonemal beta dynein heavy chain 5) (HL1). 4.07 0.04353262 DNAH5 [Source:Uniprot/SWISSPROT;Acc:Q8TE73] [ENST00000382416] 3.81 0.002855909 NM_145263 SPATA18 Homo sapiens spermatogenesis associated 18 homolog (rat) (SPATA18), mRNA [NM_145263] AA418814 zw01a02.s1 Soares_NhHMPu_S1 Homo sapiens cDNA clone IMAGE:767978 3', 3.69 0.03203913 AA418814 AA418814 mRNA sequence [AA418814] AL356953 leucine-rich repeat-containing G protein-coupled receptor 6 {Homo sapiens} (exp=0; 3.63 0.0277936 THC2705989 wgp=1; cg=0), partial (4%) [THC2752981] AA484677 ne64a07.s1 NCI_CGAP_Alv1 Homo sapiens cDNA clone IMAGE:909012, mRNA 3.63 0.027098073 AA484677 AA484677 sequence [AA484677] oe06h09.s1 NCI_CGAP_Ov2 Homo sapiens cDNA clone IMAGE:1385153, mRNA sequence 3.48 0.04468495 AA837799 AA837799 [AA837799] Homo sapiens hypothetical protein LOC340109, mRNA (cDNA clone IMAGE:5578073), partial 3.27 0.031178378 BC039509 LOC643401 cds. [BC039509] Homo sapiens Fas (TNF receptor superfamily, member 6) (FAS), transcript variant 1, mRNA 3.24 0.022156298 NM_000043 FAS [NM_000043] 3.20 0.021043295 A_32_P125056 BF803942 CM2-CI0135-021100-477-g08 CI0135 Homo sapiens cDNA, mRNA sequence 3.04 0.043389246 BF803942 BF803942 [BF803942] 3.03 0.002430239 NM_015920 RPS27L Homo sapiens ribosomal protein S27-like (RPS27L), mRNA [NM_015920] Homo sapiens tumor necrosis factor receptor superfamily, member 10c, decoy without an 2.98 0.021202829 NM_003841 TNFRSF10C intracellular domain (TNFRSF10C), mRNA [NM_003841] 2.97 0.03243901 AB002384 C6orf32 Homo sapiens mRNA for KIAA0386 gene, partial cds.
    [Show full text]